NASDAQ · Biotechnology

CYPH (CYPH) Stock

$0.69 +2.20% NASDAQ: CYPH Healthcare

Valuation

MetricValue
Price$0.69
Market Cap$39.01M
P/E Ratio17.14
P/B Ratio0.44
P/S Ratio325.27
EPS (TTM)$0.00
52-Week High$3.70
52-Week Low$0.23
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE3.25%
ROA3.07%
ROCE-24.18%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio32.40

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$0$0$0$0
Operating Profit$-41.0M$-57.0M$-87.0M$-70.0M$-37.0M
Net Profit$-41.0M$-55.0M$-81.0M$-68.0M$5.0M
EPS$-4.73$-4.82$-3.98$-1.81$0.07
Op Margin-2761.7%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$118.0M$58.0M$73.0M$49.0M$163.0M
Total Liabilities$10.0M$3.0M$13.0M$14.0M$10.0M
Cash$115.0M$21.0M$71.0M$47.0M$14.0M
Borrowings$0$1.0M$0$0$0

Latest News

Winklevoss-Backed Zcash Treasury Plunges Nearly 40% on ZEC Privacy Bug Concerns decrypt · Jun 5, 2026 Top Premarket Decliners MT Newswires · Jun 5, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-35.0M$-49.0M$-44.0M$-60.0M$-44.0M
Investing Cash Flow$0$0$49.0M$0$-97.0M
Financing Cash Flow$1.0M$0$0$-3.0M$0
Net Cash Flow$63.0M$-49.0M$5.0M$-23.0M$-33.0M
Free Cash Flow$-35.0M$-49.0M$-44.0M$-60.0M$-44.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-62.99%
Quick Ratio27.28
Interest Coverage—
Return 1Y128.15%
Return 3Y-75.74%
Return 5Y-94.54%

Ownership

Insiders Held8.44%
Institutions Held14.80%
Institutions Float Held16.16%
Institutional HolderSharesReport Date
Blackrock Inc.2,342,1742026-03-31
Vanguard Capital Management LLC1,818,4142026-03-31
Renaissance Technologies, LLC725,1202026-03-31
Geode Capital Management, LLC571,0682026-03-31
Vanguard Fiduciary Trust Co297,0862026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APLMApollomics, Inc. $18.76 +2.99% -2.41 $20.69M 0.00%
ASBP $7.26 +3.13% -0.74 $837601 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
BCTX $3.53 +1.73% -0.04 $6.65M 0.00%
CRIS $4.69 -4.09% -0.35 $9.14M 0.00%

About CYPH

CYPH is led by CEO Douglas E. Onsi, employs 52 people, headquartered in US, publicly traded since 2017.

CYPH stock trades at $0.69 with a market capitalization of $39.01M. The stock is valued at a price-to-earnings (P/E) ratio of 17.14, price-to-book of 0.44, price-to-sales of 325.27. Over the past 52 weeks the stock has ranged between $0.23 and $3.70, and currently trades 81.4% below its 52-week high.

On profitability, CYPH generates a return on equity (ROE) of 3.25%, return on capital employed of -24.18%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides